By constructing an in vivo assembled, catalytically proficient peroxidase, C45, we have recently demonstrated the catalytic potential of simple, de novo-designed heme proteins. Here we show that C45's enzymatic activity extends to the efficient and stereoselective intermolecular transfer of carbenes to olefins, heterocycles, aldehydes and amines. Not only is this the first report of carbene transferase activity in a de novo protein, but also of enzyme-catalyzed ring expansion of aromatic heterocycles via carbene transfer by any enzyme.
It has been recently demonstrated that several natural heme-containing proteins and enzymes (e.g. cytochromes P450 17 , globins 18 , cytochrome c 19 ) are capable of accessing many chemistries intrinsic to the heme cofactor, not all of which are essential to lifesupporting biological roles. These reported activities are mostly dependent on accessing hypothetical heme-based carbene and nitrene intermediates 20 analogous to the oxene intermediates, compounds I and II, observed in the catalytic cycles of hemecontaining peroxidases and oxygenases 15 . The Arnold, Hartwig and Fasan groups have now reported several examples of natural and engineered hemoproteins that catalyze cyclopropanations 17 , C-H insertions 21 , N-H insertions 22 , carbonyl olefinations 23 , aziridinations 24 and carbon-silicon bond formations 19 , most of which have been exposed to several rounds of directed evolution to improve stereoselectivity and product yield. Excluding the aziridation reactions, an electrophilic metallocarbenoid intermediate (Fig.  1b) is hypothesised to be responsible for carbene transfer to a suitable nucleophile (e.g. olefin) 20, 25 . We therefore reasoned that if the metallocarbenoid intermediate could be detected spectroscopically then C45 may function as a promiscuous carbene transferase, catalyzing a range of important and challenging organic transformations.
To spectroscopically isolate the metallocarbenoid intermediate, we rapidly mixed ferrous C45 with the carbene precursor, ethyl diazoacetate (EDA) at 5 o C in a stopped-flow spectrophotometer. Concomitant with the disappearance of the ferrous C45 spectrum was the appearance of a new spectroscopically distinct species over 60 seconds, with a red-shifted Soret peak at 426 nm and broad Q-bands centred at 543 and 584 nm (Fig.  1c) . This new spectrum is consistent with those observed in experimentally-produced carbene:iron porphyrin complexes 26 . The cold conditions on rapid mixing proved essential in observing the spectroscopic intermediate, as room temperature experiments resulted in spectra indicative of carbene-induced heme degradation, consistent with a mechanism proposed by Arnold 27 .
We then investigated the ability of C45 to act as an active carbene transferase in the cyclopropanation of styrene, commonly used as a acceptor for heme protein-derived metallocarbenoids 17 . Following reactions initiated at 5 o C under anaerobic conditions, we analysed the cyclopropanation activity of C45 and hemin when mixed with EDA and styrene by chiral HPLC and LC-MS. Hemin exhibited little cyclopropanation activity, and under the reaction conditions employed here, only unreacted EDA was observed. However, analysis of the C45-catalyzed reaction revealed the presence of two peaks in the chiral HPLC at 7.23 and 9.00 mins, corresponding to the (R,R) and (S,S) enantiomers of the Et-CPC product ( Supplementary Fig. 2 ). Following base-hydrolysis of the Et-CPC to the corresponding acid (CPC) and further LC-MS and chiral HPLC analysis against commercial standards ( Supplementary Fig. 2 ), we determined that the C45-catalyzed cyclopropanation of styrene was highly diastereoselective (>95 % de), occurs at relatively high yield (69.7 %, TTN = 697) and exhibits significant enantioselectivity, with an enantiomeric excess (ee) of 77 % in favour of the (R,R) enantiomer. C45 will accept derivatised diazoacetates and para-substituted styrenes as substrates for cyclopropanation, producing products with varying stereoselectivities and yields (Fig. 2, Supplementary Figs. 3 & 4) . We postulate that the observed stereoselectivity exhibited by C45 likely results from the intrinsic asymmetry of the protein scaffold, and offers a means by which we can improve subsequent C45-derived maquettes. In fact, small-scale screening of a C45 library generated by error-prone pcr identified a double mutant of C45 (JR1: C45 G67S/A93S) with significantly improved yield (>95 % de; yield = 79.8 %; TTN = 798) and a remarkably higher enantioselectivity towards the (R,R) product (ee = 92 %) ( Supplementary Fig. 2C ). As is the case for many enzymes improved by random laboratory evolution methodologies, it is not immediately clear why these changes result in the observed enhancements 28 , but it demonstrates well the mutability and catalytic potential of the scaffold and will be explored in more depth in future work.
With stereoselective carbene transferase activity firmly established for the cyclopropanation of styrene, we explored the substrate promiscuity of C45 towards similar reactions resulting in N-H insertions and carbonyl olefinations. Following reaction conditions identical to those described above for cyclopropanation and using HPLC and LC-MS to identify insertion products, we observed the C45-catalyzed insertion of EDAderived carbene into the N-H bonds of para-chloroaniline and piperidine (Fig. 2 , Supplementary Figs . 5 -9), with single and double insertion products resulting from carbene transfer to the primary amine of para-chloroaniline. For carbonyl olefination, the addition of triphenylphosphine to the reaction mixture is necessary to facilitate the formation of an ylide that, through the generation of an oxaphosphetane intermediate, spontaneously collapses to the product 23 . We investigated the olefination of four potential aldehyde substrates: benzaldehyde, p-nitrobenzaldehyde, pcyanobenzaldehyde and 3,4,5-trimethoxybenzaldehyde. After overnight reactions were performed, the products were again analysed by HPLC and LC-MS, and though yields and TTNs were typically low, they were consistent with values reported for several myoglobin variants (Fig. 2 , Supplementary Figs. 10 -12) 23 . Interestingly, C45 did not exhibit discernible diastereoselectivity for carbonyl olefination, possibly indicating that the ylide is released from the protein prior to rearrangement and final product formation. Nevertheless, the ability to catalyze these reactions further illustrates the utility of C45 as a general carbene transferase enzyme.
Ring expansion reactions are exceptionally useful in organic synthesis as they provide a reliable and facile method for acquiring large, expanded ring systems 29, 30 . Though currently underused, the homologous ring expansion of nitrogen-containing heteroaromatics could be of considerable use in the synthesis of pharmaceuticals and natural products. While both the Buchner ring expansion 31 and Ciamician-Dennstedt reaction 32 proceed via a cyclopropane-containing bicyclic system that is subsequently ring-opened, the ring opening during the latter reaction is facilitated by the expulsion of a halogen leaving group. We therefore hypothesised that with a halogen-substituted carbene precursor, C45 would catalyze the cyclopropanation of a nitrogen-containing heteroaromatic to produce a cyclopropane-containing bicyclic system susceptible to spontaneous rearrangement (Fig. 3a) . Using the same reaction conditions as those described for C45-catalyzed styrene cyclopropanation, we investigated whether C45 could catalyze the ring expansion of pyrrole with ethyl-2-bromo-2-diazoacetate 33 as the carbene precursor. After 2 hours, the reaction was analysed using HPLC and LC-MS, confirming the production of the ring-expanded product, ethyl nicotinate at 57 % yield (TTN = 570) (Fig. 3b, Supplementary Fig. 13 ). Subsequent base-catalyzed hydrolysis of the product yields the nicotinamide and NAD(P)H precursor niacin, raising the possibility of engineering a life-sustaining, artificial biochemical pathway from pyrrole to nicotinamide reliant on the in vivo activity of C45 or a related de novo designed enzyme. To the best of our knowledge, this is the first example of any enzyme -natural, engineered or de novo -that is capable of catalyzing homologous ring expansion reactions via a carbene transfer mechanism.
With this work, we have showcased the exceptionally diverse functionality available in this simple, de novo designed heme protein. The formation of the metallocarbenoid intermediate at the C45 heme facilitates not only the cyclopropanation of styrene and its derivatives, but also extends to the insertion of carbenes into N-H bonds, the olefination of carbenes and the first description of enzyme-catalyzed ring expansion of a nitrogen heterocycle. This demonstrates that abiological function is intrinsic to these de novo designed maquettes, and that the higher complexity of natural protein frameworks, such as the globins and cytochromes P450, is not necessary to support reactivity of this type. Given the significant enhancement of yield and stereoselectivity exhibited by JR1, we have also shown that with relatively minor changes to C45, reactivity can be profoundly affected. This indicates that further yield enhancements and alternative stereoselectivities are undoubtedly achievable through directed evolution, consistent with the studies reported for the maquette's natural counterparts 17, 19, 21 . Furthermore, there are many beneficial features of C45 that compare favourably against the work described by the Arnold, Fasan and Hartwig groups: C45 is expressed at high levels in E. coli, and is functionally assembled in vivo 4 , eliminating the requirement for the in vitro incorporation of abiological metalloporphyrins 21 and raising the possibility of in vivo function 33 ; C45 is thermally stable and displays excellent tolerance in organic solvents 4 , thereby facilitating its use as a homogenous catalyst in aqueous:organic mixtures. In conclusion, this work demonstrates the biocatalytic potential and reactive promiscuity that maquettes possess, and future work will be concerned with improving the substrate scope and catalytic performance of these novel, de novo enzymes. It also reinforces our previous work 4 , demonstrating that maquettes and related de novo proteins are much more than just lab curiosities or ornaments, and are instead powerful, green catalysts that can play a valuable role in facilitating challenging organic transformations.
Methods

General & Molecular biology, protein expression and purification
All chemicals were purchased from either Sigma or Fisher Scientific. Protein expression and purification in E. coli T7 Express (NEB) from the pSHT vector was carried out as described previously 4 . Error prone PCR (epPCR) libraries of C45, with a mutation rate of 2-3 amino acid mutations, were produced using the GeneMorph II EZClone Domain Mutagenesis Kit. This mutation rate was achieved with 18.7 ng of target DNA (C45 coding sequence).
Synthesis of ethyl 2-bromo-2-diazoacetate
Ethyl 2-bromo-2-diazoacetate was synthesised as previously reported 33 . Briefly, Nbromosuccinimide (260 mmol) was added to a solution of EDA (200 mmol) and 1,8-Diazabicyclo(5.4.0)undec-7-ene (280 mmol) in CH2Cl2 (5.0 ml) at 0 °C, and the reaction mixture was stirred for 10 mins. The crude reaction mixture was washed with cold Na2S2O3 (aqueous, 3 x 5 ml) and quickly filtered through a silica column (cold CH2Cl2). Cold CH2Cl2 was added to bring the final volume up to 2.5 ml (~400 mM). Stopped flow spectrophotometry Stopped-Flow kinetics were conducted using a SX20 stopped-flow spectrophotometer (Applied Photophysics)housed in an anaerobic glovebox under N2 ([O2] < 5 ppm; Belle Technology). A solution containing a known concentration of C45 or JR1 (20 μM, 100 mM KCl, 20 mM CHES, pH 8.6) was placed in one syringe and a 20 mM solution of EDA (carbene precursor) in ethanol was placed in the second syringe. 50 μl from each syringe was simultaneously injected into a mixing chamber and the progression of the reaction was monitored spectroscopically at 5 o C and 25 o C examining the metallocarbenoid formation and porphyrin degradation pathway respectively.
Carbene Transfer Chemistry
Unless stated otherwise, all assays were conducted under scrubbed nitrogen inside an anaerobic glovebox ([O2] < 5 ppm; Belle Technology). The assays were conducted inside 1.5 ml screw top vials sealed with a silicone-septum containing cap. All assays were conducted in CHES buffer (100 mM KCl, 20 mM CHES, pH 8.6) and the final reaction volumes were 400 μl unless otherwise stated.
Cyclopropanation assays
To 370 μl of a 10 μM C45 solution was added 10 μl of Na2S2O4 (400 mM stock; deionised water) and the mixture was left to stir for 1 minute, ensuring complete reduction of C45 from Fe 3+ to Fe 2+ . 10 μl of the selected styrene (1.2 mM stock in EtOH) was added and the reaction left to mix for 30 seconds. A separate vial containing the selected diazo compound (400 mM stock in EtOH) was deoxygenated alongside the reaction vessel. The vials were sealed, transported out of the glovebox and cooled to 0 o C in an ice bath. Once cooled, 10 μl of the diazo compound was added via gastight syringe into the reaction vials to initiate the reaction. Final reaction concentrations were 10 μM enzyme, 10 mM sodium dithionite, 10 mM diazo compound, and 30 mM styrene. Once mixed, the reactions were stirred on a roller at room temperature. After 2 hours, the reaction was quenched by the addition of 20 μl of 3 M HCl. The vials were subsequently unscrewed and 1 ml of ethyl acetate was added to the vial. The solution was transferred to a 1.5 ml microcentrifuge tube, vortexed and centrifuged for 1 minute at 13,500 rpm. The upper organic layer was extracted, dried over MgSO4 if necessary, and subsequently used for analysis. Where base hydrolysis of the resultant ester was necessary,400 μl of 3 M NaOH was introduced to the organic layer and the mixture was left to stir, at room temperature for 30 minutes. Products were analysed by chiral-HPLC and LC-MS as described below. The product yields, enantiomeric excesses and total turnover numbers (TTN; concentration of product formed/concentration of enzyme) where calculated via external calibration with commercial ethyl 2-phenylcyclopropane-1-carboxylate and 2-phenylcyclopropane-1-carboxylic acid.
Carbonyl olefination assays
Carbonyl olefination assays were conducted under the same reaction conditions as the cyclopropanation assays, with the following alterations: alkene substrates were substituted for selected benzaldehyde substrates; 10 mM of PPh3 was included as an additional reagent in the reaction (10 μl of a 400 mM stock in acetone); the reactions were carried out overnight; after quenching, the products were extracted with 1 ml of dichloromethane; the products were analysed by C18 reverse-phase HPLC and LC-MS as described below. The product yields, cis/trans ratios and total turnover numbers where calculated via an external calibration with commercial ethyl cinnamate and cinnamic acid. N-H insertion assays N-H insertion assays were conducted under the same reaction conditions as the cyclopropanation assays, with the following alterations: the alkene starting materials were substituted for the selected amines; the reactions were carried out overnight; after quenching, the products were extracted with 1 ml of n-hexane; the products were subsequently analysed by C18 reverse-phase HPLC and LC-MS as described below. The product yield and total turnover numbers where calculated via an external calibration with commercial n-phenyglycine ethyl ester and n-ethylpiperidine acetate.
Ring expansion assays
Ring expansion assays were conducted under the same reaction conditions as the cyclopropanation assays described above, but with the following alterations: styrene was substituted for pyrrole; ethyl 2-bromo-2-diazoacetate was used as the carbene precursor; the products were analysed by C18 reverse-phase HPLC and LC-MS as described below. The product yields and total turnover numbers where calculated via an external calibration with commercial ethyl nicotinate and niacin. Product Characterisation by HPLC All the reactions performed using C45 and JR1 were quantified by High Performance Liquid Chromatography (HPLC). Two separate columns were employed for quantification: a reverse phase C18 column and a chiral column.
A C18 HPLC reverse phase column (Phenomenex, 150 x 15 mm, 5 μm) was used to analytically quantify ring expansion, carbonyl olefination and N-H insertion assays. A gradient (55:45 % H2O:CH3CN to 10:90 % H2O:CH3CN; 0.1 % v/v Formic acid; 2 ml.min -1 ) was employed as the mobile phase for the ring expansion assays. An isocratic polar ionic mobile phase (100 % CH3CN: 0.1 % v/v TFA: 0.1 % v/v: Et3N; 0.1 ml.min -1 for cyclopropanation, 1 ml.min -1 for carbonyl olefination and 0.2 ml.min -1 for N-H insertions) was employed for analysing the carbonyl olefination and N-H insertion assays. Injection volumes of the sample mixture were 20 μl and the elution was monitored spectroscopically at 220, 254 and 280 nm. The C18 column allowed the retention times of the starting materials and the reaction products to be determined, and to quantify the diastereoselectivity of a given reaction. If appreciable product formation could be detected after the initial HPLC experiment, the product mixture was analysed again over a 20 minute gradient (30:70% H2O:CH3CN to 10:90% H2O:CH3CN; 0.1 % v/v Formic acid; 0.5 ml.min -1 ) mobile phase. This protocol was subsequently adopted in the Liquid chromatography-Mass spectrometry (LC-MS) experiments and the retention times of the product using this protocol facilitated product hunting and data analysis. A Chirobiotic V chiral column (Astec, 25 cm x 2.1 mm, 5 μm, with a vancomycin stationary phase) was employed to analytically separate mixtures of possible product enantiomers resulting from the cyclopropanation assays. A polar ionic mobile phase (100 % CH3CN: 0.1 % v/v TFA: 0.1 % v/v: Et3N; 0.1 ml.min -1 ) was employed. Injection volumes of the sample mixture were 1-2 μl and the elution was monitored spectroscopically at 220 nm, 245 nm, 254 nm and 280 nm. Liquid chromatography-Mass spectrometry (LC-MS) was employed to quantify product formation in each assay. A C18 reverse column (Phenomenex, 150 x 10, 5 μm), identical to the column employed in the HPLC experiments, was used and flow rate of 0.5 ml.min -1 over a 20 minute gradient (30:70 % H2O:CH3CN to 10:90 % H2O:CH3CN; 0.1% v/v Formic acid) was adopted as the mobile phase. Injection volumes of 20 μl were employed and the chromatogram was screened across a wavelength range of 240-300 nm. After eluting from the column, the mixture entered an isocratic solvent chamber where a 1:100 dilution was performed prior to injecting the sample into a positive electron-spray-ionisation (ESI) mass spectrometer (Waters Xevo G2-XS QTof). The mass spectrum contained peaks screened across a m/z range of 70-250. Retention times were initially determined using HPLC to facilitate product hunting and data analysis. External calibrations were conducted using HPLC with commercial standards corresponding to the expected products of the assays. The conditions and mobile phases employed in the product analysis for each assay was employed for the calibrations. Each substrate was prepared at multiple concentrations (500 μM, 1 mM, 2 mM, 5 mM, 7.5 mM, 10 mM, and 20 mM) and the peak height response in the chromatogram was recorded. A plot of [substrate] vs peak height engendered a straight line which could be used to determine the product yields for each assay.
